Last reviewed · How we verify

NCT02993601

Feasibility Study of a New Peripheral Oedema Monitor for Heart Failure

Completed Last updated 13 October 2021
What this trial tests

trial testing Heartfelt-1 in Heart Failure, Diastolic in 70 participants. Completed in 13 June 2017.

Timeline
15 January 2017
Primary endpoint
13 June 2017
13 June 2017

Quick facts

Lead sponsorHeartfelt Technologies
StatusCompleted
Study typeOBSERVATIONAL
Enrollment70
Start date15 January 2017
Primary completion13 June 2017
Estimated completion13 June 2017
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Heartfelt Technologies — full company profile →

Who can join

Adults 18 to 99, any sex, with Heart Failure, Diastolic or Edema Brain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims at assessing the usefulness of the Heartfelt1 device in patients suffering from heart failure, who have peripheral oedema. The device is non-contact and does not requires patient compliance to work. It gives an output reading of the patient's lower leg volume. During the study, this measurement will be compared to clinical standard and gold standard measurements as well as clinical grading of peripheral oedema.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation of the Accuracy of a Video and AI Solution to Measure Lower Leg and Foot Volume.
    Chausiaux O, Williams G, Nieznański M, Bagdu A, et al · · 2021 · cited 7× · PMID 33880069 · DOI 10.2147/mder.s297713

Verify or expand the search:

Other recruiting trials for Heart Failure, Diastolic

Currently open trials in the same condition.

Other Heartfelt Technologies trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02993601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing